|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Acromegaly | |||||
| Diabetes | |||||
| Insulin Resistance | |||||
| Impaired Glucose Tolerance | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Glucose Intolerance | |||||
| 3 | More general conditions related to this trial | ||||
| Bone Diseases | |||||
| Bone Diseases, Endocrine | |||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Endocrine System Diseases | |||||
| Glucose Metabolism Disorders | |||||
| Hyperglycemia | |||||
| Hyperinsulinism | |||||
| Hyperpituitarism | |||||
| Hypothalamic Diseases | |||||
| Metabolic Diseases | |||||
| Musculoskeletal Diseases | |||||
| Nervous System Diseases | |||||
| Pituitary Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| University Hospital Tuebingen | |||||
| Pfizer | |||||
| Ludwig-Maximilians - University of Munich | |||||